Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Amortization - Intangibles (2016 - 2026)

Cumberland Pharmaceuticals' Amortization - Intangibles history spans 16 years, with the latest figure at $1.0 million for Q4 2025.

  • On a quarterly basis, Amortization - Intangibles fell 30.57% to $1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.0 million, a 15.03% decrease, with the full-year FY2025 number at $4.0 million, down 15.03% from a year prior.
  • Amortization - Intangibles hit $1.0 million in Q4 2025 for Cumberland Pharmaceuticals, roughly flat from $1.0 million in the prior quarter.
  • Over the last five years, Amortization - Intangibles for CPIX hit a ceiling of $4.5 million in Q4 2023 and a floor of $458222.0 in Q4 2022.
  • Historically, Amortization - Intangibles has averaged $1.3 million across 5 years, with a median of $1.1 million in 2023.
  • Biggest five-year swings in Amortization - Intangibles: surged 890.6% in 2023 and later crashed 67.85% in 2024.
  • Tracing CPIX's Amortization - Intangibles over 5 years: stood at $1.0 million in 2021, then plummeted by 54.95% to $458222.0 in 2022, then surged by 890.6% to $4.5 million in 2023, then plummeted by 67.85% to $1.5 million in 2024, then crashed by 30.57% to $1.0 million in 2025.
  • Business Quant data shows Amortization - Intangibles for CPIX at $1.0 million in Q4 2025, $1.0 million in Q3 2025, and $1.0 million in Q2 2025.